Following encouraging clinical results, retatrutide, a novel peptide therapy for addressing type 2 hyperglycemia , has obtained official approval from Great Britain's Medicines and Regulatory Agency ( https://shopretatrutidepeptide.com/category/retatrutide-peptide/